Nuclear Radiology

The rise of theranostics: Part 5 -- Advice from center administrators
By Liz Carey
Want to launch theranostics at your hospital and cancer center? An SNMMI 2024 session provided key planning steps.
July 12, 2024
Nuclear medicine technologist and theranostics practice administrator Dmitry Beyder (left) and Vikas Prasad, MD, PhD (right), lead the theranostics center at Barnes-Jewish Hospital/Washington University in Saint Louis, MO. Image courtesy of Washington University.
The rise of theranostics: Part 3 -- What is a theranostics center?
By Liz Carey
For this third in a series covering the rise of theranostics, AuntMinnie.com asked four doctors of theranostics to discuss the spectrum of freestanding theranostics center development.
June 3, 2024
Part3 Riseof Thernaostics Cover
Evergreen Theragnostics raises $26M
By AuntMinnie.com staff writers
Evergreen Theragnostics has completed a $26 million capital raise through its existing shareholders and new backers Petrichor and LIFTT.
April 19, 2024
Money Bills 400
IMV: Nuclear medicine procedure volumes decrease
By Davin Korstjens
Total nuclear medicine patient study volumes decreased between 2021 and 2023, according to a newly published IMV 2024 Nuclear Medicine Market Outlook Report.
April 15, 2024
Pet Scan
Life Molecular Imaging, Sofie add Neuraceq availability out of Ohio
By AuntMinnie.com staff writers
Life Molecular Imaging and Sofie Biosciences have begun offering the Neuraceq PET radiotracer produced at Sofie's radiopharmaceutical manufacturing site in Cleveland, Ohio.
April 5, 2024
Brain Puzzle Dementia Social
RSNA calls out toxicity concerns with theranostics
By AuntMinnie.com staff writers
RSNA experts recommend proceeding conservatively with theranostic treatments until dose limits to normal organs are established.
March 22, 2024
Yellow Caution Tape Social
Clarity reports on third cohort in copper theranostic trial
By AuntMinnie.com staff writers
Australian radiopharmaceutical developer Clarity Pharmaceuticals has completed the third cohort in the theranostic SECuRE trial.
March 15, 2024
Prostate Cancer 400
Cannabis may influence bowel motility
By Will Morton
Physicians, health care providers, and medical staff caring for patients who use cannabis should be familiar with the effects of the drug on gut motility, a recent report advises.
March 11, 2024
Cannabis
Hold off on the Egg McMuffins before GES tests, experts say
By Will Morton
Nuclear medicine technologists are being advised that not just any meal works for patients before gastric emptying scintigraphy (GES).
March 7, 2024
Stomach
IMV: PET scan volumes continue to grow
By Davin Korstjens
The total volume of PET scans increased 10.2% year over year in 2023, according to the newly published IMV 2024 PET Market Summary Report.
March 7, 2024
Pet Scan
PET lung scan times could be cut by half
By Will Morton
Dynamic PET scans acquired in half the time of normal scans appear clinically feasible for patients with lung lesions.
March 6, 2024
A 60-year-old male patient with clinical suspicion of lung cancer. PET/CT scan showed FDG-avid pulmonary nodules in the upper lobe of the left lung (red arrow), with a size of 2.2 × 1.3 cm, SUVmax of 12.2, Ki-65 min of 0.016 ml/g/min, and Ki-30 min of 0.014 ml/g/min. Surgical pathology confirmed a granulomatous lesion. In addition, PET/CT scan showed many FDG-avid lung nodules in the mediastinum. (A, static PET maximum intensity projection; B, static PET SUV image; C, static PET/CT fusion image; D, dynamic PET Ki-65 min image; E, dynamic PET Ki-30 min image). Image courtesy of EJNMMI Physics.
Fusion Pharmaceuticals settles with Heidelberg University and Euratom
By AuntMinnie.com staff writers
Fusion Pharmaceuticals announced a patent dispute settlement and new licensing agreement with Heidelberg University and Euratom.
February 16, 2024
Executives Handshake
Page 1 of 80
Next Page